Houston Methodist 7th Annual Hepatology Update for Primary Care 2025
+ Include: 5 videos + 5 audios + 5 file sub vtts + 1 pdf, size: 1.96 GB
+ Target Audience: primary care physicians, internists, hospitalists, family medicine practitioners
+ Information:
Liver diseases have become more prevalent and primary care healthcare professionals and practitioners face challenges in prompt recognition, diagnosis and management. The burden of liver ailments is further expected to increase.
The goal of this meeting is to provide an overview of the most common liver diseases seen in the community and to bridge the learning gap between primary care and the latest advances and developments in the field of hepatology. Given the rapid pace of clinical growth in hepatology in the past decade, bridging this gap is particularly significant. A practical approach will be presented that attendees can integrate into their daily practice.
Target Audience
Primary care physicians, internists, hospitalists, family medicine practitioners, physician assistants, nurse practitioners, nurses, residents, fellows, and medical students will benefit from this course.
Learning Objectives
Upon completion of this live activity, the participant should be able to:
- Identify the natural history and progression of non-alcoholic fatty liver disease (NAFLD)
- Describe the basics of therapeutics
- Identify recent updates in the treatment of viral hepatitis
- Identify the current approach to alcoholic liver disease, and the impact of the COVID-19 pandemic on this condition
+ Topics:
| TIME | PRESENTATION | SPEAKER |
| 8:30 AM | Registration and Breakfast | |
| 9:15 AM | Welcome, Introduction, and Conference Overview | Rashid Khan, MD, FACP, FACG, FAASLD |
| 9:30 AM | Evaluation of Abnormal Liver Tests | Tamneet Basra, MD |
| 10:00 AM | Viral Hepatitis Update | Michelle Jones-Pauley, DO, MS |
| 10:30 AM | Break and Exhibits | |
| 11:00 AM | Drug-Induced Liver Injury | Chukwuma Egwim, MD |
| 11:30 AM | Alcoholic Liver Disease Update | Kavish Patidar, DO |
| 12:00 PM | Break and Lunch | |
| 12:30 PM | Fatty Liver Disease Update | Mazen Noureddin, M.D., MHSc |
| 1:00 PM | Adjourn | |



